Spectral AI (MDAI)
Develops DeepView to assess burn wounds before treatment decisions.
$1.66
After hours−0.01 (−0.30%)
At close$1.67(+0.30%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 5 | 6 | 7 | 8 | 8 | 7 | 5 | 4 | 4 | 4 | 4 |
| Cost of revenue | 2 | 3 | 3 | 4 | 5 | 4 | 4 | 3 | 2 | 2 | 2 | 2 |
| Gross profit | 1 | 2 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 |
| 6 | 5 | 5 | 6 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 5 | |
| Research & development | 0 | 0 | 0 | 7 | 8 | 0 | 4 | 3 | 0 | 4 | 0 | 2 |
| 6 | 5 | 5 | 6 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| General & administrative | 6 | 5 | 5 | 6 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 3 |
| Other expenses | 0 | 0 | 0 | −7 | −8 | 0 | −3 | −3 | 0 | −4 | 0 | 0 |
| Operating income | −4 | −3 | −2 | −2 | −1 | −1 | −1 | −2 | −3 | −2 | −2 | −4 |
| −7 | −1 | −1 | 0 | −1 | −6 | 4 | −6 | 0 | 3 | −1 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 |
| Other non-operating income | 7 | 1 | 1 | 0 | 0 | 6 | −4 | 6 | 0 | −4 | 1 | −1 |
| Income before tax | −11 | −4 | −3 | −3 | −1 | −8 | 3 | −8 | −4 | 1 | −3 | −4 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −11 | −4 | −3 | −3 | −2 | −8 | 3 | −8 | −4 | 1 | −3 | −4 |
| Other adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | −11 | −4 | −3 | −3 | −2 | −8 | 3 | −8 | −4 | 1 | −3 | −4 |
| EPS, basic | −$0.77 | −$0.22 | −$0.19 | −$0.16 | −$0.08 | −$0.41 | $0.13 | −$0.31 | −$0.13 | $0.02 | −$0.11 | −$0.13 |
| EPS, diluted | −$0.77 | −$0.22 | −$0.19 | −$0.16 | −$0.08 | −$0.41 | $0.11 | −$0.31 | −$0.13 | $0.02 | −$0.11 | −$0.13 |
| Weighted average shares, basic | 14 | 16 | 17 | 18 | 18 | 19 | 23 | 25 | 26 | 30 | 32 | 32 |
| Weighted average shares, diluted | 14 | 16 | 17 | 18 | 18 | 19 | 24 | 25 | 26 | 30 | 32 | 32 |
| EBITDA | −11 | −3 | −3 | −2 | 0 | −7 | 4 | −8 | −3 | 1 | −3 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −11 | −4 | −3 | −2 | 0 | −7 | 4 | −8 | −3 | 1 | −3 | −4 |